HUE040387T2 - Piridopirimidin-származékok - Google Patents
Piridopirimidin-származékokInfo
- Publication number
- HUE040387T2 HUE040387T2 HUE15840871A HUE15840871A HUE040387T2 HU E040387 T2 HUE040387 T2 HU E040387T2 HU E15840871 A HUE15840871 A HU E15840871A HU E15840871 A HUE15840871 A HU E15840871A HU E040387 T2 HUE040387 T2 HU E040387T2
- Authority
- HU
- Hungary
- Prior art keywords
- pyridopyrimidines
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462049506P | 2014-09-12 | 2014-09-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE040387T2 true HUE040387T2 (hu) | 2019-03-28 |
Family
ID=55454107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE15840871A HUE040387T2 (hu) | 2014-09-12 | 2015-09-11 | Piridopirimidin-származékok |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US10280162B2 (hu) |
| EP (1) | EP3191099B1 (hu) |
| JP (1) | JP6661606B2 (hu) |
| KR (1) | KR20170054408A (hu) |
| CN (2) | CN107074847A (hu) |
| AR (1) | AR101813A1 (hu) |
| AU (1) | AU2015316120B2 (hu) |
| BR (1) | BR112017004919A2 (hu) |
| CA (1) | CA2958331C (hu) |
| CL (1) | CL2017000582A1 (hu) |
| CO (1) | CO2017001709A2 (hu) |
| ES (1) | ES2701273T3 (hu) |
| HU (1) | HUE040387T2 (hu) |
| IL (1) | IL250968B (hu) |
| MX (1) | MX2017003067A (hu) |
| PL (1) | PL3191099T3 (hu) |
| PT (1) | PT3191099T (hu) |
| WO (1) | WO2016037255A2 (hu) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170204089A1 (en) | 2014-08-04 | 2017-07-20 | Drexel University | Novel compounds and methods of treating or ameliorating an il-1r-mediated disease or disorder using same |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA02012659A (es) | 2000-06-26 | 2003-09-22 | Lilly Icos Llc | Derivados de pirazindiona condensados. |
| CN1275964C (zh) | 2000-08-31 | 2006-09-20 | 霍夫曼-拉罗奇有限公司 | 作为细胞增殖抑制剂的7－氧代吡啶并嘧啶 |
| CA2427608C (en) * | 2000-11-08 | 2010-05-04 | Lilly Icos Llc | Condensed pyradizindione derivatives as pde inhibitors |
| FR2896246B1 (fr) * | 2006-01-13 | 2008-08-15 | Sanofi Aventis Sa | Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique. |
| DE602007006947D1 (de) * | 2006-05-23 | 2010-07-15 | Hoffmann La Roche | Pyridopyrimidinonderivate |
| US20100035867A1 (en) * | 2006-07-11 | 2010-02-11 | Guerrant Richard L | Inhibitors of Cyclic Nucleotide Synthesis and Their Use for Therapy of Various Diseases |
| US7474231B2 (en) * | 2006-07-12 | 2009-01-06 | Alcatel-Lucent Usa Inc. | Radio communications for vehicle speed adjustment |
| UY33535A (es) * | 2010-08-13 | 2011-12-01 | Biolab Sanus Farmaceutuca Limitada | Derivados de 6,7-dihidro-3h-oxazolo[3,4]pirazin-5,8-diona |
| US20150152101A1 (en) * | 2012-06-06 | 2015-06-04 | L'oreal | Active compounds for combating greasy skin |
-
2015
- 2015-09-11 EP EP15840871.6A patent/EP3191099B1/en active Active
- 2015-09-11 JP JP2017507425A patent/JP6661606B2/ja not_active Expired - Fee Related
- 2015-09-11 ES ES15840871T patent/ES2701273T3/es active Active
- 2015-09-11 BR BR112017004919A patent/BR112017004919A2/pt active Search and Examination
- 2015-09-11 WO PCT/BR2015/050147 patent/WO2016037255A2/en active Application Filing
- 2015-09-11 AR ARP150102896A patent/AR101813A1/es unknown
- 2015-09-11 HU HUE15840871A patent/HUE040387T2/hu unknown
- 2015-09-11 MX MX2017003067A patent/MX2017003067A/es active IP Right Grant
- 2015-09-11 PT PT15840871T patent/PT3191099T/pt unknown
- 2015-09-11 US US14/851,072 patent/US10280162B2/en active Active
- 2015-09-11 AU AU2015316120A patent/AU2015316120B2/en not_active Ceased
- 2015-09-11 CN CN201580048066.0A patent/CN107074847A/zh active Pending
- 2015-09-11 PL PL15840871T patent/PL3191099T3/pl unknown
- 2015-09-11 CA CA2958331A patent/CA2958331C/en active Active
- 2015-09-11 KR KR1020177007199A patent/KR20170054408A/ko active IP Right Grant
- 2015-09-11 CN CN202210592377.5A patent/CN114751905A/zh active Pending
-
2017
- 2017-02-22 CO CONC2017/0001709A patent/CO2017001709A2/es unknown
- 2017-03-06 IL IL250968A patent/IL250968B/en active IP Right Grant
- 2017-03-09 CL CL2017000582A patent/CL2017000582A1/es unknown
-
2019
- 2019-03-25 US US16/363,431 patent/US10822333B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112017004919A2 (pt) | 2017-12-12 |
| KR20170054408A (ko) | 2017-05-17 |
| CL2017000582A1 (es) | 2017-11-24 |
| CN114751905A (zh) | 2022-07-15 |
| AU2015316120B2 (en) | 2018-05-17 |
| IL250968A0 (en) | 2017-04-30 |
| CA2958331A1 (en) | 2016-03-17 |
| WO2016037255A2 (en) | 2016-03-17 |
| US20180111926A2 (en) | 2018-04-26 |
| AU2015316120A1 (en) | 2017-01-12 |
| PT3191099T (pt) | 2018-12-18 |
| CN107074847A (zh) | 2017-08-18 |
| US10280162B2 (en) | 2019-05-07 |
| CA2958331C (en) | 2019-12-17 |
| EP3191099A2 (en) | 2017-07-19 |
| US10822333B2 (en) | 2020-11-03 |
| US20160075702A1 (en) | 2016-03-17 |
| JP6661606B2 (ja) | 2020-03-11 |
| WO2016037255A3 (en) | 2016-06-30 |
| MX2017003067A (es) | 2017-06-14 |
| IL250968B (en) | 2020-03-31 |
| AR101813A1 (es) | 2017-01-11 |
| PL3191099T3 (pl) | 2019-07-31 |
| ES2701273T3 (es) | 2019-02-21 |
| CO2017001709A2 (es) | 2017-03-31 |
| EP3191099B1 (en) | 2018-11-14 |
| JP2017526666A (ja) | 2017-09-14 |
| US20190218216A1 (en) | 2019-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201706729SA (en) | Derivatives of sobetirome | |
| IL263050B (en) | History of Subtirum | |
| SI3524234T1 (sl) | Trdne oblike sofosbuvira | |
| SG11201609205WA (en) | Heterocyclyl-butanamide derivatives | |
| HUE050450T2 (hu) | Fluoralkil-fluorén-származékok | |
| IL246979A0 (en) | Crystalline forms of sofosbuvir | |
| IL248773A0 (en) | History of naphthyridinedione | |
| PL3164393T3 (pl) | Pochodne flawaglin | |
| RS59218B1 (sr) | Novi derivati cyp-eikosanoida | |
| IL248629B (en) | Substances containing diheteroaryl conjugated to cycloalkyl and their uses | |
| PL3119744T3 (pl) | Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu | |
| IL249130B (en) | Preparation of piperidine-4-carbothioamide | |
| SG11201605072VA (en) | Azaindole derivative | |
| IL250968A0 (en) | New compounds derived from pyridopyrimidines | |
| IL249332A0 (en) | Crystalline forms of sofosbuvir |